ePrints
Items where Author is "Morganti-Kossmann, MC"
Up a level |
Group by: Item Type | No Grouping
Number of items: 5.
Hellewell, SC, Mondello, S, Conquest, A, Shaw, G, Madorsky, I, Deng, JV, Little, L, Kobeissy, F, Bye, N ORCID: 0000-0003-0976-5870, Bellomo, R, Cooper, DJ, Vallance, S, Board, J and Morganti-Kossmann, MC 2017
, 'Erythropoietin Does Not Alter Serum Profiles of Neuronal and Axonal Biomarkers After Traumatic Brain Injury: Findings From the Australian EPO-TBI Clinical Trial'
, Critical care medicine
, pp. 1-8
, doi: https://doi.org/10.1097/CCM.0000000000002938.
Hellewell, SC, Mondello, S, Conquest, A, Shaw, G, Madorsky, I, Deng, JV, Little, L, Kobeissy, F, Bye, N ORCID: 0000-0003-0976-5870, Bellomo, R, Cooper, DJ, Vallance, S, Board, J and Morganti-Kossmann, MC 2017
, 'Erythropoietin Does Not Alter Serum Profiles of Neuronal and Axonal Biomarkers After Traumatic Brain Injury: Findings From the Australian EPO-TBI Clinical Trial'
, Critical care medicine, vol. 46, no. 4
, pp. 554-561
, doi: https://doi.org/10.1097/CCM.0000000000002938.
Morganti-Kossmann, MC, Semple, BD, Hellewell, SC, Bye, N ORCID: 0000-0003-0976-5870 and Ziebell, JM ORCID: 0000-0003-2497-4347 2018
, 'The complexity of neuroinflammation consequent to traumatic brain injury: from research evidence to potential treatments'
, Acta Neuropathologica
, pp. 1-25
, doi: https://doi.org/10.1007/s00401-018-1944-6.
Nhiem Tran, N, Bye, N ORCID: 0000-0003-0976-5870, Moffat, BA, Wright, DK, Cuddihy, A, Hinton, TM, Hawley, AM, Reynolds, NP, Waddington, LJ, Mulet, X, Turnley, AM, Morganti-Kossmann, MC and Muir, BW 2017
, 'Dual-modality NIRF-MRI cubosomes and hexosomes: High throughput formulation and in vivo biodistribution'
, Materials Science & Engineering C-Materials for Biological Applications, vol. 71
, pp. 584-593
, doi: https://doi.org/10.1016/j.msec.2016.10.028.
Woodcock, TM, Frugier, T, Nguyen, TT, Semple, BD, Bye, N ORCID: 0000-0003-0976-5870, Massara, M, Savino, B, Besio, R, Sobacchi, C, Locati, M and Morganti-Kossmann, MC 2017
, 'The scavenging chemokine receptor ACKR2 has a significant impact on acute mortality rate and early lesion development after traumatic brain injury'
, PLoS one, vol. 12, no. 11
, pp. 1-21
, doi: https://doi.org/10.1371/journal.pone.0188305.
This list was generated on Thu Jun 1 02:13:55 2023 AEST.